Pathogenesis of Graves' Ophthalmopathy

New England Journal of Medicine

Volumn 329, Issue 20, 1993, Pages 1468-1475

  Epstein, Franklin H ^a   Bahn, Rebecca S ^b   Heufelder, Armin E ^c  

^a Mayo Clinic and Foundation ^*

^b MAYO CLINIC   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEAT SHOCK PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 1ALPHA; THYROTROPIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANTIBODY FORMATION; GLYCOSAMINOGLYCANS; GRAVES' DISEASE; HEAT-SHOCK PROTEINS; HUMAN; RECEPTORS, THYROTROPIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0027365837     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199311113292007     Document Type: Review

References (63)

1. Teng CS, Yeo PPB Ophthalmic Graves's disease: natural history and detailed thyroid function studies. BMJ 1977; 1: 273-275
2. Bahn RS, Garrity JA, Gorman CA Diagnosis and management of Graves' ophthalmopathy. J Clin Endocrinol Metab 1990; 71: 559-563
3. Smith TJ, Bahn RS, Gorman CA Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989; 10: 366-391
4. Shine B, Fells P, Edwards OM, Weetman AP Association between Graves' ophthalmopathy and smoking. Lancet 1990; 335: 1261-1263
5. Prummel MF, Wiersinga WM Smoking and risk of Graves' disease. JAMA 1993; 269: 479-482
6. Tallstedt L, Lundell G, Torring O, Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 1992; 326: 1733-1738
7. Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R Amelioration of eye changes of Graves' ophthalmopathy by achieving euthyroidism. Acta Endocrinol (Copenh) 1989; 121: Suppl 2: 185-189
8. Frecker M, Stenszky V, Balazs C, Kozma L, Kraszits E, Farid NR Genetic factors in Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1986; 25: 479-485
9. Werner SC, Coleman DJ, Franzen LA Ultrasonographic evidence of a consistent orbital involvement in Graves's disease. N Engl J Med 1974; 290: 1447-1450
10. Salvi M, Zhang Z-G, Haegert D, Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities. J Clin Endocrinol Metab 1990; 70: 89-94
11. Marcocci C, Bartalena L, Bogazzi FM, Panicucci M, Pinchera A Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol (Copenh) 1989; 120: 473-478
12. Wortsman J, Dietrich J, Traycoff RB, Stone S Preradial myxedema in thyroid disease. Arch Dermatol 1981; 117: 635-638
13. Campbell RJ. Pathology of Graves' ophthalmopathy. In: Gorman CA, Waller RR, Dyer JA, eds. The eye and orbit in thyroid disease. New York: Raven Press, 1984:25-31.
14. Kahaly G, Schuler M, Sewell AC, Bernhard G, Beyer J, Krause U Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1990; 33: 35-44
15. Koornneef L Eyelid and orbital fascial attachments and their clinical significance. Eye 1988; 2: 130-134
16. Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 1984; 91: 1411-1419
17. Tallstedt L, Norberg R Immunohistochemical staining of normal and Graves' extraocular muscle. Invest Ophthalmol Vis Sci 1988; 29: 175-184
18. Weetman AP, Cohen S, Gatter KC, Fells P, Shine B Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989; 75: 222-227
19. Heufelder AE, Bahn RS Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993; 23: 10-17
20. Hansson HA, Petruson B, Skottner A Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin. Lancet 1986; 1: 218-219
21. McKenzie JM, Zakarija M, Sato A Humoral immunity in Graves' disease. Clin Endocrinol Metab 1978; 7: 31-45
22. Shillinglaw J, Utiger RD Failure of retro-orbital tissue to neutralize the biological activity of the long-acting thyroid stimulator. J Clin Endocrinol Metab 1968; 28: 1069-1070
23. Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 1986; 62: 357-367
24. Atkinson S, Holcombe M, Kendall-Taylor P Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet 1984; 2: 374-376
25. Kadlubowski M, Irvine WJ, Rowland AC The lack of specificity of ophthalmic immunoglobulins in Graves' disease. J Clin Endocrinol Metab 1986; 63: 990-995
26. Miller A, Sikorska H, Salvi M, Wall JR Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves' ophthalmopathy. Acta Endocrinol (Copenh) 1986; 113: 514-522
27. Bahn RS, Gorman CA, Woloschak GE, Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. J Clin Endocrinol Metab 1987; 65: 665-670
28. Salvi M, Miller A, Wall JR Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 1988; 232: 135-139
29. Bahn RS, Gorman CA, Johnson CM, Smith TJ Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein. J Clin Endocrinol Metab 1989; 69: 622-628
30. Ahmann A, Baker JR, Weetman AP, Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 1987; 64: 454-460
31. Schifferdecker E, Ketzler-Sasse U, Boehm BO, Ronsheimer HB, Scherbaum WA, Schoffling K Re-evaluation of eye muscle autoantibody determination in Graves' ophthalmopathy: failure to detect a specific antigen by use of enzyme-linked immunosorbent assay, indirect immunofluorescence, and immunoblotting techniques. Acta Endocrinol (Copenh) 1989; 121: 643-650
32. Weightman D, Kendall-Taylor P Cross-reaction of eye muscle antibodies with thyroid tissue in thyroid-associated ophthalmopathy. J Endocrinol 1989; 122: 201-206
33. Rosen CE, Raikow RB, Burde RM, Kennerdell JS, Mosseri M, Scalise D Immunohistochemical evidence for IgA1 involvement in Graves ophthalmopathy. Ophthalmology 1992; 99: 146-152
34. Salvi M, Bernard N, Miller A, Zhang ZG, Gardini E, Wall JR Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 1991; 1: 207-213
35. Kendler DL, Rootman J, Huber GK, Davies TF A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves' thyroid and ophthalmic diseases. Clin Endocrinol (Oxf) 1991; 35: 539-547
36. Dong Q, Ludgate M, Vassart G Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1991; 72: 1375-1381
37. Ross PV, Koenig RJ, Arscott P, Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease. J Clin Endocrinol Metab 1993; 77: 433-438
38. Weetman AP Thyroid-associated ophthalmopathy. Autoimmunity 1992; 12: 215-221
39. Weetman AP Thyroid-associated eye disease: pathophysiology. Lancet 1991; 338: 25-28
40. Weetman AP Autoimmunity in Graves' ophthalmopathy: a review. J R Soc Med 1989; 82: 153-158
41. Munro RE, Lamki L, Row VV, Volpe R Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab 1973; 37: 286-292
42. Wall JR, Walters BAJ, Grant C Leukocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy. J Endocrinol Invest 1979; 2: 375-378
43. Prummel MF, Wiersinga WM, Van der Gaag R, Mourits MP, Koornneef L Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. Clin Exp Immunol 1992; 88: 405-409
44. Heufelder AE, Bahn RS Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy. Clin Exp Immunol 1993; 91: 381-389
45. Springer TA Adhesion receptors of the immune system. Nature 1990; 346: 425-434
46. Heufelder AE, Bahn RS Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. Eur J Clin Invest 1992; 22: 529-537
47. Lindquist S The heat-shock response. Annu Rev Biochem 1986; 55: 1151-1191
48. Kaufmann SHE Heat shock proteins and the immune response. Immunol Today 1990; 11: 129-136
49. Wenzel BE, Franke TF, Heufelder AE, Hessemann J Autoimmune thyroid diseases and enteropathogenic Yersinia enterocolitica. Autoimmunity 1990; 7: 295-303
50. Heufelder AE, Wenzel BE, Gorman CA, Bahn RS Detection, cellular localization, and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves' disease. J Clin Endocrinol Metab 1991; 73: 739-745
51. Heufelder AE, Wenzel BE, Bahn RS Cell surface localization of a 72 kilodalton heat shock protein in retroocular fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 1992; 74: 732-736
52. Heufelder AE, Goellner JR, Wenzel BE, Bahn RS Immunohistochemical detection and localization of a 72-kilodalton heat shock protein in autoimmune thyroid disease. J Clin Endocrinol Metab 1992; 74: 724-731
53. Korducki JM, Loftus SJ, Bahn RS Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts. Invest Ophthalmol Vis Sci 1992; 33: 2037-2042
54. Smith TJ, Bahn RS, Gorman CA, Cheavens M Stimulation of glycosaminoglycan accumulation by interferon γ in cultured human retroocular fibroblasts. J Clin Endocrinol Metab 1991; 72: 1169-1171
55. Sisson JC Stimulation of glucose utilization and glycosaminoglycans production by fibroblasts derived from retrobulbar tissue. Exp Eye Res 1971; 12: 285-292
56. Heufelder AE, Bahn RS. Modulation of orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists. Invest Ophthalmol Vis Sci (in press).
57. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid (in press).
58. Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV, Fenzi G Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 1993; 342: 337-338
59. Smith TJ, Bahn RS, Gorman CA Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts. J Clin Endocrinol Metab 1989; 69: 1019-1023
60. Imai Y, Odajima R, Inoue Y, Shishiba Y Effect of growth factors on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts of Graves' ophthalmopathy in culture. Acta Endocrinol (Copenh) 1992; 126: 541-552
61. Heufelder AE, Smith TJ, Gorman CA, Bahn RS Increased induction of HLA-DR by interferon-γ in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy. J Clin Endocrinol Metab 1991; 73: 307-313
62. Prummel MF, Mourits MP, Berghout A, Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med 1989; 321: 1353-1359
63. Dinarello CA, Wolff SM The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106-113